877 related articles for article (PubMed ID: 28093254)
41. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
42. Schisantherin B ameliorates Aβ
Xu M; Dong Y; Wan S; Yan T; Cao J; Wu L; Bi K; Jia Y
Physiol Behav; 2016 Dec; 167():265-273. PubMed ID: 27660034
[TBL] [Abstract][Full Text] [Related]
43. Cognitive enhancing and antioxidant effects of tetrahydroxystilbene glucoside in Aβ1-42-induced neurodegeneration in mice.
Xie M; Zhang G; Yin W; Hei XX; Liu T
J Integr Neurosci; 2018; 17(3-4):355-365. PubMed ID: 29125494
[TBL] [Abstract][Full Text] [Related]
44. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
[TBL] [Abstract][Full Text] [Related]
45. Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages.
Serrano FG; Tapia-Rojas C; Carvajal FJ; Cisternas P; Viayna E; Sola I; Munoz-Torrero D; Inestrosa NC
Curr Alzheimer Res; 2016; 13(9):1017-29. PubMed ID: 26502813
[TBL] [Abstract][Full Text] [Related]
46. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
47. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
Mahaman YAR; Huang F; Wu M; Wang Y; Wei Z; Bao J; Salissou MTM; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Chen D; Wang X
J Alzheimers Dis; 2018; 63(3):1141-1159. PubMed ID: 29710724
[TBL] [Abstract][Full Text] [Related]
48. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
[TBL] [Abstract][Full Text] [Related]
49. 2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis.
Tian JS; Zhai QJ; Zhao Y; Chen R; Zhao LD
J Integr Neurosci; 2017; 16(4):385-400. PubMed ID: 28891528
[TBL] [Abstract][Full Text] [Related]
50. An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.
Gao HL; Li C; Nabeka H; Shimokawa T; Wang ZY; Cao YM; Matsuda S
J Alzheimers Dis; 2016 Jun; 53(3):1173-92. PubMed ID: 27372641
[TBL] [Abstract][Full Text] [Related]
51. [Effect of hyperforin on learning and memory abilities and Aβ₁₋₄₂, βAPP and BACE1 protein expressions in hippocampus of Alzheimer's disease model mice].
Geng YN; Wu YJ; Zhang WX
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2877-2882. PubMed ID: 28914032
[TBL] [Abstract][Full Text] [Related]
52. Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ
Xiang X; Wang X; Jin S; Hu J; Wu Y; Li Y; Wu X
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110423. PubMed ID: 34363866
[TBL] [Abstract][Full Text] [Related]
53. Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.
Sachdeva AK; Chopra K
J Nutr Biochem; 2015 Jul; 26(7):736-44. PubMed ID: 25869595
[TBL] [Abstract][Full Text] [Related]
54. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
[TBL] [Abstract][Full Text] [Related]
55. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
[TBL] [Abstract][Full Text] [Related]
56. Resveratrol ameliorates spatial learning memory impairment induced by Aβ
Wang R; Zhang Y; Li J; Zhang C
Neuroscience; 2017 Mar; 344():39-47. PubMed ID: 27600946
[TBL] [Abstract][Full Text] [Related]
57. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
58. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
59. Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer's disease associated mice.
Wang DD; Li J; Yu LP; Wu MN; Sun LN; Qi JS
J Integr Neurosci; 2016 Jun; 15(2):247-60. PubMed ID: 27338163
[TBL] [Abstract][Full Text] [Related]
60. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
